Skip to main content

Table 2 Five-year adjusted conditional PCSM for patients with T4, N1, or M1 disease

From: Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis

5-year PCSM

T4

N1

M1

at diagnosis

13.9 % (ref)

18.9 % (ref)

57.2 % (ref)

after 5 years

11.2 % (p < 0.001)

21.4 % (p < 0.001)

41.4 % (p < 0.001)

after 10 years

8.1 % (p < 0.001)

17.6 % (p = 0.055)

28.8 % (p < 0.001)

after 15 years

6.5 % (p < 0.001)

13.8 % (p < 0.001)

20.8 % (p < 0.001)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us